ÖZET
Amaç:
Kronik baş ağrısı olan hastaların ilaç profilaksisine uyunç oranlarını ve bu oranı etkileyen, internet ve sosyal medya kullanımı gibi faktörleri belirlemektir.
Yöntemler:
Bu çalışma Mayıs ve Eylül 2021 tarihleri arasında iki hastanede yürütülmüştür. Çalışmaya profilaksi tedavisi gerektiren kronik baş ağrısı olan yetişkin hastalar alınmıştır. Demografik veriler, baş ağrısı tipleri/özellikleri, profilaktik ilaçlar, Hastane Anksiyete ve Depresyon ölçeği skorları ve internet/sosyal medya kullanım süresi (saat/gün) kaydedilmiştir. İlaç Uyuncu Bildirim ölçeği puanları, baş ağrısı özelliklerindeki değişiklikler ve ilaçla ilişkili yan etkiler birinci ayda değerlendirilmiştir
Bulgular:
Çalışmaya 113 hasta dahil edilmiştir. Birinci ay ilaç uyunç oranının %72,6 olduğu görülmüş ve hastaların çoğunda migren varlığı (%69) tespit edilmiştir. İnternet/sosyal medya kullanım süresinin uzamasının ve ilaç yan etkisi varlığının ilaç uyunçsuzluğunu artırdığı görülmüştür (p=0,005). Başlangıçta maksimum baş ağrısı şiddetinin düşük olmasının ilaç uyuncu olasılığını azalttığı saptanmıştır (p=0,005). Devlet hastanesi hastalarının (p=0,036) ve evli hastaların (p=0,048) uyunçsuzluğa daha yatkın olduğu görülmüştür.
Sonuç:
İnternet/sosyal medya kullanımı, baş ağrısı şiddeti ve ilaca bağlı yan etkiler ilaç uyuncu ile ilişkili en önemli faktörlerdir. Kar amacı gütmeyen sağlık kuruluşları, ilaç uyuncunu artırmak için internet ve sosyal medyayı iletişim kanalları olarak kullanmalıdır. Sağlık politikalarının sağlık çalışanı-hasta diyaloğuna daha fazla zaman tanıyacak şekilde düzenlenmesi tedavi uyuncunu artırabilir.
References
1
Ramsey RR, Ryan JL, Hershey AD, Powers SW, Aylward BS, Hommel KA. Treatment adherence in patients with headache: a systematic review. Headache 2014; 54: 795-816.
2
Gaul C, van Doorn C, Webering N, Dlugaj M, Katsarava Z, Diener HC, et al. Clinical outcome of a headache-specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary headache center: an observational study. J Headache Pain 2011; 12: 475-83.
3
Marín-Gracia M, Hernando-Quintana N, López-Bravo A, García-Arguedas C, Navarro-Pérez MP, Garcés-Antón E, et al. Degree of compliance with treatment at three months in migraine patients. Rev Neurol 2021; 72: 377-83.
4
Dozza AL, Krymchantowski AV. Adherence to migraine treatment does not depend on the number of prescribed medications. Arq Neuropsiquiatr 2013; 71: 171-3.
5
García-Azorin D, Yamani N, Messina LM, Peeters I, Ferrili M, Ovchinnikov D, et al.; European Headache Federation School of Advanced Studies (EHF-SAS). A PRISMA-compliant systematic review of the endpoints employed to evaluate symptomatic treatments for primary headaches. J Headache Pain 2018; 19: 90.
6
Linde M, Jonsson P, Hedenrud T. Influence of disease features on adherence to prophylactic migraine medication. Acta Neurol Scand 2008; 118: 367-72.
7
Hepp Z, Dodick DW, Varon SF, Gillard P, Hansen RN, Devine EB. Adherence to oral migraine-preventive medications among patients with chronic migraine. Cephalalgia 2015; 35: 478-88.
8
Rains JC, Lipchik GL, Penzien DB. Behavioral facilitation of medical treatment for headache--part I: Review of headache treatment compliance. Headache 2006; 46: 1387-94.
9
Hepp Z, Bloudek LM, Varon SF. Systematic review of migraine prophylaxis adherence and persistence. J Manag Care Pharm 2014; 20: 22-33.
10
Baumgartner SE, Hartmann T. The role of health anxiety in online health information search. Cyberpsychol Behav Soc Netw 2011; 14: 613-8.
11
Hawn C. Take two aspirin and tweet me in the morning: how Twitter, Facebook, and other social media are reshaping health care. Health Aff (Millwood) 2009; 28: 361-8.
12
Im H, Huh J. Does Health Information in Mass Media Help or Hurt Patients? Investigation of Potential Negative Influence of Mass Media Health Information on Patients’ Beliefs and Medication Regimen Adherence. J Health Commun 2017; 22: 214-22.
13
De Martino I, D’Apolito R, McLawhorn AS, Fehring KA, Sculco PK, Gasparini G. Social media for patients: benefits and drawbacks. Curr Rev Musculoskelet Med 2017; 10: 141-5.
14
Haydabrus A, Linskiy I, Giménez-Llort L. Social Media Use, Fake News and Mental Health during the Uncertain Times of the COVID-19 Pandemic in Ukraine. Behav Sci (Basel) 2023; 13: 339.
15
L Lee Y, Jeon YJ, Kang S, Shin JI, Jung YC, Jung SJ. Social media use and mental health during the COVID-19 pandemic in young adults: a meta-analysis of 14 cross-sectional studies. BMC Public Health 2022; 22: 995.
16
Suarez-Lledo V, Alvarez-Galvez J. Prevalence of Health Misinformation on Social Media: Systematic Review. J Med Internet Res 2021; 23: e17187.
17
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018; 38: 1-211.
18
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-70.
19
Aydemir Ö, Güvenir T, Küey L, Kültür S. Reliability and Validity of the Turkish version of Hospital Anxiety and Depression Scale. Turkish Journal of Psychiatry 1997; 8: 280-7.
20
Chan AHY, Horne R, Hankins M, Chisari C. The Medication Adherence Report Scale: A measurement tool for eliciting patients’ reports of nonadherence. Br J Clin Pharmacol 2020; 86: 1281-8.
21
Esin TŞ, Sertel Berk Ö, Dilşad S. The validity and reliability study of the Turkish adaptation of medical adherence report scale. J Istanb Fac Med 2019; 82: 52-61.
22
Orlando V, Mucherino S, Monetti VM, Trama U, Menditto E. Treatment patterns and medication adherence among newly diagnosed patients with migraine: a drug utilisation study. BMJ Open 2020; 10: e038972.
23
Meyers JL, Davis KL, Lenz RA, Sakai F, Xue F. Treatment patterns and characteristics of patients with migraine in Japan: A retrospective analysis of health insurance claims data. Cephalalgia 2019; 39: 1518-1534.
24
Packard RC, O’Connell P. Medication compliance among headache patients. Headache 1986; 26: 416-9.
25
Seok JI, Cho HI, Chung CS. From transformed migraine to episodic migraine: reversion factors. Headache 2006; 46: 1186-90.
26
Reidy BL, Powers SW, Coffey CS, Chamberlin LA, Ecklund DJ, Klingner EA, et al. Multimodal Assessment of Medication Adherence Among Youth With Migraine: An Ancillary Study of the CHAMP Trial. J Pediatr Psychol 2022; 47: 376-87.
27
Rahimtoola H, Buurma H, Tijssen CC, Leufkens HG, Egberts AC. Migraine prophylactic medication usage patterns in The Netherlands. Cephalalgia 2003; 23: 293-301.
28
Kovalchuk NA, Kiryanova EA, Tabeeva GR. Medication adherence in migraine patients (data of an online survey). Neurology, Neuropsychiatry Psychosomotics 2021; 13: 81-7.
29
Özcan A, Avcı İA. The influence of the pandemic on fear of contagion, blood pressure management and adherence to medication in hypertensive older adults in Turkey. J Hum Hypertens 2022; 36: 852-9.
30
Hassen LM, Almaghlouth IA, Hassen IM, Daghestani MH, Almohisen AA, Alqurtas EM, et al. Impact of COVID‐19 outbreak on rheumatic patients’ perceptions and behaviors: A cross‐sectional study. Int J Rheum Dis 2020; 23: 1541-9.
31
Aremu TO, Oluwole OE, Adeyinka KO, Schommer JC. Medication Adherence and Compliance: Recipe for Improving Patient Outcomes. Pharmacy (Basel) 2022; 10: 106.
32
Do TP, Andreou AP, de Oliveira AB, Shapiro RE, Lampl C, Amin FM. The increasing role of electronic media in headache. BMC Neurol 2023; 23: 194.
33
Bory P, Crabu S, Morsello B, Tomasi M, Tosoni S. Rethinking the Nexus between Science, Politics and Society in the Age of the SARS-CoV-2 Pandemic. Tecnoscıenza 2021; 12: 140-87.
34
Al Khaja KAJ, AlKhaja AK, Sequeira RP. Drug information, misinformation, and disinformation on social media: a content analysis study. J Public Health Policy 2018; 39: 343-57.
35
Thomas J, Peterson GM, Walker E, Christenson JK, Cowley M, Kosari S, et al. Fake news: Medicines misinformation by the media. Clin Pharmacol Ther 2018; 104: 1059-61.
36
Saffi H, Do TP, Hansen JM, Dodick DW, Ashina M. The migraine landscape on YouTube: A review of YouTube as a source of information on migraine. Cephalalgia 2020; 40: 1363-9.
37
Bojazar R, Do TP, Hansen JM, Dodick DW, Ashina M. Googling migraine: a study of Google as an information resource of migraine management. Cephalalgia 2020; 40: 1633-44.
38
Ashina M, Katsarava Z, Do TP, Buse DC, Pozo-Rosich P, Özge A, et al. Migraine: epidemiology and systems of care. Lancet 2021; 397: 1485-95.
39
Beier D, Callesen HE, Carlsen LN, Birkefoss K, Tómasdóttir H, Wűrtzen H, et al. Manual joint mobilisation techniques, supervised physical activity, psychological treatment, acupuncture and patient education in migraine treatment. A systematic review and meta-analysis. Cephalalgia 2022; 42: 63-72.
40
Gomaa BTM. Leveraging Informatics to Understand Online Communication Patterns Between Migraine Sufferers on Social Media. PhD Thesis. University of Minnesota. 2021.
41
Fagerlin A, Wang C, Ubel PA. Reducing the influence of anecdotal reasoning on people’s health care decisions: is a picture worth a thousand statistics? Med Decis Making 2005; 25: 398-405.
42
Chou WY, Hunt YM, Beckjord EB, Moser RP, Hesse BW. Social media use in the United States: implications for health communication. J Med Internet Res 2009; 11: e48.
43
Acikgoz M, Piri Cinar B, Celebi U, Aciman Demirel E, Karpuz Seren B, Atasoy HT. Illness perception and quality of life in patients with migraine and tension-type headache. Neurol Res 2023; 45: 370-80.
44
Durmuş V. Differences in health literacy level of patients from public and private hospitals: a cross-sectional study in Turkey. Public Health 2021; 200: 77-83.
45
Karsandi A, Özkan S, Dibek K, Arslan ED. The effect of patient evaluation times on diagnosis in crowded emergency services. Phoenix Med J 2021; 3: 5-10.
46
Turkish Medical Association (2021) TTB ve Tabip Odaları İşyerlerinden Seslendi: 5 Dakikada Hekimlik Yapılmaz, Sağlık 5 Dakikaya Sığmaz! Available from https://www.ttb.org.tr/245yis8. (Accessed 26 Nowember 2022)
47
Yıldız GH, Kubilay Ö. Neoliberal Health Policies and Doctor Migration. Sci Acad Res 2022; 1: 1-13.
48
Verma A, Kiran K, Kumar A. Relationships Between Beliefs about Medication, Seizure Control and Adherence to Antiepileptic Drugs Among People with Epilepsy. Arch Clin Med Case Rep 2020; 4: 1031-7.
49
Hedenrud T, Jonsson P, Linde M. Beliefs About Medicines and Adherence Among Swedish Migraineurs. Ann Pharmacother 2008; 42: 39-45.
50
Kvarnström K, Westerholm A, Airaksinen M, Liira H. Factors Contributing to Medication Adherence in Patients with a Chronic Condition: A Scoping Review of Qualitative Research. Pharmaceutics 2021; 13: 1100.
